OTT-Managed DOE Portfolios

OTT/DOE Notes:

  OTT continues to manage a portfolio of 71 inventions for the DOE Laboratories, most disclosed prior to the establishment of the DOE independent licensing offices. However, OTT continues to receive some new disclosures when UC campuses are also involved or the technology is closely related to one already administered by OTT.

  The majority of activity involves LLNL’s 54 inventions, over half of which are licensed. Of the 17 inventions from LBNL and LANL, four are licensed, four are being actively marketed and most of the rest are older patented inventions that are not likely to be licensed.

  Both LBNL’s Liposome Delivery System for Chemotherapeutic drugs and LLNL’s Chromosome Painting technologies earned substantial income in FY96, resulting in a dramatic increase in adjusted gross income. For the Liposome Delivery System, a minimum royalty of $100,000 was received in FY96, and the annual royalty is scheduled to increase in FY97. Chromosome Painting Technologies generated $180,000 in FY96. No income was received in FY95 due to a delay in the issuance of the primary patent. This patent now has issued and substantial ongoing royalties are anticipated.

  Net legal expenses include the University share of FY96 litigation costs for an infringement involving the Chromosome Painting technologies. These are being split with the licensee.

  Due to the unique nature of the DOE Labs and the fact that they do not receive State funds, as of FY96 the Labs are no longer subject to a State share assessment.

  The sharp increase in income, coupled with other factors noted above, resulted in a net gain for the OTT-managed DOE Laboratories portfolio of $43,000, reversing the $165,000 loss in FY95.

INVENTION ACTIVITY (OTT/DOE)

Previous Page
Back to Table of Contents (for frame-less browsers only)